Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Debt (2016 - 2025)

Mimedx's Total Debt history spans 11 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Total Debt fell 4.58% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $18.0 million, down 4.58%, while the annual FY2025 figure was $18.0 million, 4.58% down from the prior year.
  • Total Debt for Q4 2025 was $18.0 million at Mimedx, down from $18.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $49.1 million in Q4 2023 and bottomed at $18.0 million in Q4 2025.
  • The 5-year median for Total Debt is $48.0 million (2021), against an average of $36.7 million.
  • The largest annual shift saw Total Debt grew 1.04% in 2023 before it crashed 61.65% in 2024.
  • A 5-year view of Total Debt shows it stood at $48.1 million in 2021, then rose by 0.97% to $48.6 million in 2022, then grew by 1.04% to $49.1 million in 2023, then tumbled by 61.65% to $18.8 million in 2024, then fell by 4.58% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Total Debt are $18.0 million (Q4 2025), $18.2 million (Q3 2025), and $18.5 million (Q2 2025).